1
-
2
of
2
results (0.41 seconds)
Sort By:
-
Biosimilars, Part 5: Payer Decision Making
decision-making? prescription drug costs, managed care By Gregory Warren and Tony Pistilli Health Watch ... generally have some essential requirements, one primary goal and a couple secondary goals (Figure 1). Figure ...- Authors: Greg Warren, Tony Pistilli
- Date: Jan 2024
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability; Health & Disability>Chronic health management - Health & Disability; Health & Disability>Health care; Health & Disability>Health insurance
-
Biosimilars, Part 6: Maximizing Adoption
oncology, rheumatology, ophthalmology and diabetes care, around 90 percent or more of the prescribers surveyed ... biosimilars in rheumatology, ophthalmology and diabetes care seems to be lower. That said, 72 percent of prescribers ...
- Authors: Tony Pistilli, Greg Warren
- Date: Jan 2024
- Competency: External Forces & Industry Knowledge
- Publication Name: Health Watch
- Topics: Health & Disability